Development and Characterization of Polylactic Acid-Resveratrol-Based Polymeric Nanoparticles and Their Cytotoxic Effect on Two Breast Cancer Cell Lines in Combination with Doxorubicin.
- DOI
- 10.3390/pharmaceutics18080974
- Published
- 2026 Aug 8
- Container
- Pharmaceutics
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3390/pharmaceutics18080974,
title = {Development and Characterization of Polylactic Acid-Resveratrol-Based Polymeric Nanoparticles and Their Cytotoxic Effect on Two Breast Cancer Cell Lines in Combination with Doxorubicin.},
author = {López Barrera LD and Santillan Morales KY and Martínez Rosas JR and Soria-Castro E and Ramírez Noguera P and Ganem Rondero FA and Diaz-Torres R},
year = {2026},
journal = {Pharmaceutics},
doi = {10.3390/pharmaceutics18080974},
url = {https://doi.org/10.3390/pharmaceutics18080974}
}RIS
TY - JOUR TI - Development and Characterization of Polylactic Acid-Resveratrol-Based Polymeric Nanoparticles and Their Cytotoxic Effect on Two Breast Cancer Cell Lines in Combination with Doxorubicin. AU - López Barrera LD AU - Santillan Morales KY AU - Martínez Rosas JR AU - Soria-Castro E AU - Ramírez Noguera P AU - Ganem Rondero FA AU - Diaz-Torres R PY - 2026 JO - Pharmaceutics DO - 10.3390/pharmaceutics18080974 UR - https://doi.org/10.3390/pharmaceutics18080974 ER -
APA
LD, L. B., KY, S. M., JR, M. R., E, S., P, R. N., FA, G. R., & R, D. (2026). Development and Characterization of Polylactic Acid-Resveratrol-Based Polymeric Nanoparticles and Their Cytotoxic Effect on Two Breast Cancer Cell Lines in Combination with Doxorubicin.. Pharmaceutics. https://doi.org/10.3390/pharmaceutics18080974
Source records
- pubmed · retrieved 2026-09-25T09:21:07.796Z